Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line (Translation: The University of Toledo Journal of Medical Sciences, 2025)
Keywords: Neurosciences; Bioinformatics; CTNNB1 Syndrome